The Multicopper Oxidase of Mycobacterium Tuberculosis (Mmco)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Nucleotide Degradation
Nucleotide Degradation Nucleotide Degradation The Digestion Pathway • Ingestion of food always includes nucleic acids. • As you know from BI 421, the low pH of the stomach does not affect the polymer. • In the duodenum, zymogens are converted to nucleases and the nucleotides are converted to nucleosides by non-specific phosphatases or nucleotidases. nucleases • Only the non-ionic nucleosides are taken & phospho- diesterases up in the villi of the small intestine. Duodenum Non-specific phosphatases • In the cell, the first step is the release of nucleosides) the ribose sugar, most effectively done by a non-specific nucleoside phosphorylase to give ribose 1-phosphate (Rib1P) and the free bases. • Most ingested nucleic acids are degraded to Rib1P, purines, and pyrimidines. 1 Nucleotide Degradation: Overview Fate of Nucleic Acids: Once broken down to the nitrogenous bases they are either: Nucleotides 1. Salvaged for recycling into new nucleic acids (most cells; from internal, Pi not ingested, nucleic Nucleosides acids). Purine Nucleoside Pi aD-Rib 1-P (or Rib) 2. Oxidized (primarily in the Phosphorylase & intestine and liver) by first aD-dRib 1-P (or dRib) converting to nucleosides, Bases then to –Uric Acid (purines) –Acetyl-CoA & Purine & Pyrimidine Oxidation succinyl-CoA Salvage Pathway (pyrimidines) The Salvage Pathways are in competition with the de novo biosynthetic pathways, and are both ANABOLISM Nucleotide Degradation Catabolism of Purines Nucleotides: Nucleosides: Bases: 1. Dephosphorylation (via 5’-nucleotidase) 2. Deamination and hydrolysis of ribose lead to production of xanthine. 3. Hypoxanthine and xanthine are then oxidized into uric acid by xanthine oxidase. Spiders and other arachnids lack xanthine oxidase. -
35 Disorders of Purine and Pyrimidine Metabolism
35 Disorders of Purine and Pyrimidine Metabolism Georges van den Berghe, M.- Françoise Vincent, Sandrine Marie 35.1 Inborn Errors of Purine Metabolism – 435 35.1.1 Phosphoribosyl Pyrophosphate Synthetase Superactivity – 435 35.1.2 Adenylosuccinase Deficiency – 436 35.1.3 AICA-Ribosiduria – 437 35.1.4 Muscle AMP Deaminase Deficiency – 437 35.1.5 Adenosine Deaminase Deficiency – 438 35.1.6 Adenosine Deaminase Superactivity – 439 35.1.7 Purine Nucleoside Phosphorylase Deficiency – 440 35.1.8 Xanthine Oxidase Deficiency – 440 35.1.9 Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency – 441 35.1.10 Adenine Phosphoribosyltransferase Deficiency – 442 35.1.11 Deoxyguanosine Kinase Deficiency – 442 35.2 Inborn Errors of Pyrimidine Metabolism – 445 35.2.1 UMP Synthase Deficiency (Hereditary Orotic Aciduria) – 445 35.2.2 Dihydropyrimidine Dehydrogenase Deficiency – 445 35.2.3 Dihydropyrimidinase Deficiency – 446 35.2.4 Ureidopropionase Deficiency – 446 35.2.5 Pyrimidine 5’-Nucleotidase Deficiency – 446 35.2.6 Cytosolic 5’-Nucleotidase Superactivity – 447 35.2.7 Thymidine Phosphorylase Deficiency – 447 35.2.8 Thymidine Kinase Deficiency – 447 References – 447 434 Chapter 35 · Disorders of Purine and Pyrimidine Metabolism Purine Metabolism Purine nucleotides are essential cellular constituents 4 The catabolic pathway starts from GMP, IMP and which intervene in energy transfer, metabolic regula- AMP, and produces uric acid, a poorly soluble tion, and synthesis of DNA and RNA. Purine metabo- compound, which tends to crystallize once its lism can be divided into three pathways: plasma concentration surpasses 6.5–7 mg/dl (0.38– 4 The biosynthetic pathway, often termed de novo, 0.47 mmol/l). starts with the formation of phosphoribosyl pyro- 4 The salvage pathway utilizes the purine bases, gua- phosphate (PRPP) and leads to the synthesis of nine, hypoxanthine and adenine, which are pro- inosine monophosphate (IMP). -
Xanthine Oxidase Assay (XO) Cat
Xanthine Oxidase Assay (XO) Cat. No. 8458 100 Tests in 96-well plate Introduction Xanthine Oxidase (XO) located predominantly in the liver and intestine in mammalian tissues and catalyzes the hydroxylation of hypoxanthine to xanthine and then to uric acid and hydrogen peroxide. XO activity is normally very low in blood and liver injury can result in the release of XO into blood. XO activity or expression can be up-regulated in gout and cardiovascular disease. This colorimetric assay is based on XO-catalyzed oxidation of xanthine, in which the formed hydrogen peroxide is catalyzed by peroxidase and reacts with 4-aminoantipyrine to form the product dye. The color intensity of the reaction product at 550nm is directly proportional to XO activity in the sample. Kit Components Cat. No. # of vials Reagent Quantity Storage 8458a 1 Assay buffer 10 mL 4°C 8458b 1 Xanthine Oxidase standard 0.2 mL -20°C 8458c 1 Xanthine 2.0 mL -20°C 8458d 1 Substrate mix 1.6 mL -20°C 8458e 1 Enzyme mix 0.1 mL -20°C Product Use The Xanthine Oxidase Assay kit measures the xanthine oxidase level of different types of samples, such as serum, plasma, tissues. This product is for research purposes only and not for use in animals, humans, or diagnostic procedures. Quality Control Serially diluted xanthine oxidase solutions with concentrations ranging from 7.81 to 125 mU/mL are measured with the ScienCell™ Xanthine Oxidase Assay kit. The increase in OD550nm is monitored as a function of time (Figure 1) and the resulting standard curve of ∆OD550nm/min vs xanthine oxidase activity are plotted (Figure 2). -
Xanthine Oxidoreductase in Cancer
Cancer Medicine Open Access REVIEW Xanthine oxidoreductase in cancer: more than a differentiation marker Maria Giulia Battelli, Letizia Polito, Massimo Bortolotti & Andrea Bolognesi Department of Experimental, Diagnostic and Specialty Medicine – DIMES, Alma Mater Studiorum – University of Bologna, General Pathology Unit, Via S. Giacomo 14, 40126 Bologna, Italy Keywords Abstract Differentiation, oncogenesis, reactive oxygen and nitrogen species, uric acid, xanthine Human xanthine oxidoreductase (XOR) catalyzes the last two steps of purine oxidoreductase catabolism and is present in two interconvertible forms, which may utilize O2 or NAD+ as electron acceptors. In addition to uric acid, XOR products may Correspondence comprise reactive oxygen and nitrogen species that have many biologic effects, Letizia Polito, Department of Experimental, including inflammation, endothelial dysfunction, and cytotoxicity, as well as Diagnostic and Specialty Medicine – DIMES, mutagenesis and induction of proliferation. XOR is strictly modulated at the Alma Mater Studiorum – University of Bologna, General Pathology Unit, Via S. transcriptional and post-translational levels, and its expression and activity are Giacomo 14, 40126 Bologna, Italy. highly variable in cancer. Xanthine oxidoreductase (XOR) expression has been Tel: +39 051 2094700; Fax: +39 051 2094746; negatively associated with a high malignity grade and a worse prognosis in E-mail: [email protected] neoplasms of the breast, liver, gastrointestinal tract, and kidney, which normally express a high level of XOR protein. However, the level of XOR expression Funding Information may be associated with a worse outcome in cancer of low XOR-expressing cells, This work was supported by the Pallotti in relation to the inflammatory response elicited through the tissue damage Legacies for Cancer Research. -
Monitoring the Redox Status in Multiple Sclerosis
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 31 July 2020 doi:10.20944/preprints202007.0737.v1 Review Monitoring the Redox Status in Multiple Sclerosis Masaru Tanaka 1,2 and László Vécsei 1,2,* 1 MTA-SZTE, Neuroscience Research Group, Semmelweis u. 6, Szeged, H-6725 Hungary; [email protected] 2 Department of Neurology, Interdisciplinary Excellence Centre, Faculty of Medicine, University of Szeged, Semmelweis u. 6, H-6725 Szeged, Hungary * Correspondence: [email protected]; Tel.: +36-62-545-351 Received: date; Accepted: date; Published: date Abstract: Worldwide, over 2.2 million people are suffered from multiple sclerosis (MS), a multifactorial demyelinating disease of the central nervous system, characterized by multifocal inflammatory or demyelinating attacks associated with neuroinflammation and neurodegeneration. The blood, cerebrospinal fluid, and postmortem brain samples of MS patients evidenced the presence of reduction-oxidation (redox) homeostasis disturbance such as the alternations of oxidative and antioxidative enzyme activities and the presence of degradation products. This review article discussed the components of redox homeostasis including reactive chemical species, oxidative enzymes, antioxidative enzymes, and degradation products. The reactive chemical species covered frequently discussed reactive oxygen/nitrogen species, rarely featured reactive chemicals such as sulfur, carbonyls, halogens, selenium, and nucleophilic species that potentially act as reductive as well as pro-oxidative stressors. The antioxidative enzyme systems covered the nuclear factor erythroid-2-related factor 2 (NRF2)-Kelch-like ECH-associated protein 1 (KEAP1) signaling pathway, a possible biomarker sensitive to the initial phase of oxidative stress. Altered components of the redox homeostasis in MS were discussed, some of which turned to be MS subtype- or treatment-specific and thus potentially become diagnostic, prognostic, predictive, and/or therapeutic biomarkers. -
Nucleotide Metabolism II
Nucleotide Metabolism II • Biosynthesis of deoxynucleotides • Salvage Pathway • Catabolism: Purines • Catabolism: Pyrimidines • Feedback inhibition in purine nucleotide biosynthesis CPS II • Cytosolic CPS II uses glutamine as the nitrogen donor to carbamoyl phosphate Regulation of pyrimidine synthesis •CPSII is allosterically regulated: PRPP and IMP are activators Several pyrimidines are inhibitors • Aspartate transcarbamoylase (ATCase) Important regulatory point in prokaryotes Catalyzes the first committed pathway step Allosteric regulators: CTP (-), CTP + UTP (-), ATP (+) • Regulation of pyrimidine nucleotide synthesis in E. coli Biosynthesis of deoxynucleotides • Uses diphosphates (ribo) • Ribonucleotide reducatase • 2 sub-units • R1- reduces, active and two allosteric sites (activity and specificity site) • R2- tyrosine radical carries electrons • removes 2' OH to H Ribonucleotide reductase reaction • removes 2' OH to H • Thioredoxin and NADPH used to regenerate sulfhydryl groups Thymidylate synthesis • UDP ------> dUMP • dUMP --------> dTMP • required THF • methylates uracil Regulation THF • Mammals cannot conjugate rings or synthesize PABA. • So must get in diet. • Sulfonamides effective in bacteria due to competitive inhibition of the incorporation of PABA Cancer Drugs • fluorouracil-- suicide inhibitor of Thy synthase • aminopterin • Methotrexate -- inhibits DHF reductase Salvage of Purines and Pyrimidines • During cellular metabolism or digestion, nucleic acids are degraded to heterocyclic bases • These bases can be salvaged -
PDF, Evaluation of Ceruloplasmin Ferroxidase Activity and Lipid Profiles
Journal of Physics: Conference Series PAPER • OPEN ACCESS Evaluation of Ceruloplasmin ferroxidase activity and lipid profiles in patients with Valvular heart diseases To cite this article: H K Sacheat et al 2021 J. Phys.: Conf. Ser. 1879 022066 View the article online for updates and enhancements. This content was downloaded from IP address 170.106.202.126 on 24/09/2021 at 22:30 Ibn Al-Haitham International Conference for Pure and Applied Sciences (IHICPS) IOP Publishing Journal of Physics: Conference Series 1879 (2021) 022066 doi:10.1088/1742-6596/1879/2/022066 Evaluation of Ceruloplasmin ferroxidase activity and lipid profiles in patients with Valvular heart diseases H K Sacheat1, S Z Hussein1*and S S Al-Mudhaffar2 1 Department of Chemistry, College of Sciences, University of Baghdad 2 Ibn Al-Bitar Specialized Cardiac Surgery Centre / Baghdad - Iraq *E.mail : [email protected] Abstract. One of the major health problems causing defects or damage to one or more of the four heart valves [aortic, mitral, pulmonary, and tricuspid] is valvular heart disease [VHD]; it occurs due to congenital abnormalities or acquired pathology. It is a defect that results in weak heart valves and is therefore unable to function as precise pathways of the blood. The aim of the current study was to evaluate the ferroxidase activity of ceruloplasmin (Cp) and the lipid profile of valvular heart disease patients in sera. Ninety subjects were included in this study and 60 patients with HDV were divided into two subgroups according to the affected valve: 33 patients with aortic valve disease (AV) and 27 patients with mitral valve disease (MV group). -
Crystal Structures of Multicopper Oxidase Cueo G304K Mutant
www.nature.com/scientificreports OPEN Crystal structures of multicopper oxidase CueO G304K mutant: structural basis of the increased Received: 17 November 2017 Accepted: 5 September 2018 laccase activity Published: xx xx xxxx Hanqian Wang1, Xiaoqing Liu2, Jintong Zhao2, Qingxia Yue2, Yuhua Yan1,3, Zengqiang Gao4, Yuhui Dong1,4, Zhiyong Zhang5, Yunliu Fan2, Jian Tian2, Ningfeng Wu2 & Yong Gong1 The multicopper oxidase CueO is involved in copper homeostasis and copper (Cu) tolerance in Escherichia coli. The laccase activity of CueO G304K mutant is higher than wild-type CueO. To explain this increase in activity, we solved the crystal structure of G304K mutant at 1.49 Å. Compared with wild- type CueO, the G304K mutant showed dramatic conformational changes in methionine-rich helix and the relative regulatory loop (R-loop). We further solved the structure of Cu-soaked enzyme, and found that the addition of Cu ions induced further conformational changes in the R-loop and methionine-rich helix as a result of the new Cu-binding sites on the enzyme’s surface. We propose a mechanism for the enhanced laccase activity of the G304K mutant, where movements of the R-loop combined with the changes of the methionine-rich region uncover the T1 Cu site allowing greater access of the substrate. Two of the G304K double mutants showed the enhanced or decreased laccase activity, providing further evidence for the interaction between the R-loop and the methionine-rich region. The cuprous oxidase activity of these mutants was about 20% that of wild-type CueO. These structural features of the G304K mutant provide clues for designing specifc substrate-binding mutants in the biotechnological applications. -
Fragment of Human Ceruloplasmin (Protein Structure/Ferroxidase/Copper Binding/Genetic Polymorphism/Evolution) I
Proc. Natl. Acad. Sci. USA Vol. 76, No. 4, pp. 1668-1672, April 1979 Biochemistry Complete amino acid sequence of a histidine-rich proteolytic fragment of human ceruloplasmin (protein structure/ferroxidase/copper binding/genetic polymorphism/evolution) I. BARRY KINGSTON*, BRIONY L. KINGSTONt, AND FRANK W. PUTNAMt Department of Biology, Indiana University, Bloomington, Indiana 47405 Contributed by Frank W. Putnam, January 22, 1979 ABSTRACT The complete amino acid sequence has been a chain of human ceruloplasmin studied by McCombs and determined for a fragment of human ceruloplasmin [ferroxidase; Bowman (6) and probably corresponds to the a subunit pro- iron(II)oxygen oxidoreductase, EC 1.16.3.1]. The fragment posed by Simons and Bearn (4) and the chain of (designated Cp F5) contains 159 amino acid residues and has light Freeman a molecular weight of 18,650; it lacks carbohydrate, is rich in and Daniel (5). histidine, and contains one free cysteine that may be part of a The relation of Cp F5 to the structure of the intact cerulo- copper-binding site. This fragment is present in most commer- plasmin chain has to be deduced from indirect observations cial preparations of ceruloplasmin, probably owing to proteo- because of the small amount of single-chain ceruloplasmin lytic degradation, but can also be obtained by limited cleavage available to us and the strong interaction of the fragments. From of single-chain ceruloplasmin with plasmin. Cp F5 probably is the kinetics of the proteolytic cleavage of intact ceruloplasmin an intact domain attached to the COOH-terminal end of sin- gle-chain ceruloplasmin via a labile interdomain peptide bond. -
Finding New Enzymes from Bacterial Physiology: a Successful Approach Illustrated by the Detection of Novel Oxidases in Marinomonas Mediterranea
Mar. Drugs 2010, 8, 519-541; doi:10.3390/md8030519 OPEN ACCESS Marine Drugs ISSN 1660-3397 www.mdpi.com/journal/marinedrugs Review Finding New Enzymes from Bacterial Physiology: A Successful Approach Illustrated by the Detection of Novel Oxidases in Marinomonas mediterranea Antonio Sanchez-Amat 1,*, Francisco Solano 2 and Patricia Lucas-Elío 1 1 Department of Genetics and Microbiology, Faculty of Biology, University of Murcia, Campus de Espinardo, Murcia 30100, Spain; E-Mail: [email protected] 2 Department of Biochemistry and Molecular Biology B and Immunology, School of Medicine, University of Murcia, Murcia 30100, Spain; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +34-868884955; Fax: +34-868883963. Received: 10 February 2010; in revised form: 21 February 2010 / Accepted: 22 February 2010 / Published: 5 March 2010 Abstract: The identification and study of marine microorganisms with unique physiological traits can be a very powerful tool discovering novel enzymes of possible biotechnological interest. This approach can complement the enormous amount of data concerning gene diversity in marine environments offered by metagenomic analysis, and can help to place the activities associated with those sequences in the context of microbial cellular metabolism and physiology. Accordingly, the detection and isolation of microorganisms that may be a good source of enzymes is of great importance. Marinomonas mediterranea, for example, has proven to be one such useful microorganism. This Gram-negative marine bacterium was first selected because of the unusually high amounts of melanins synthesized in media containing the amino acid L-tyrosine. The study of its molecular biology has allowed the cloning of several genes encoding oxidases of biotechnological interest, particularly in white and red biotechnology. -
BMC Structural Biology Biomed Central
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central BMC Structural Biology BioMed Central Research article Open Access Crystal structure of a blue laccase from Lentinus tigrinus: evidences for intermediates in the molecular oxygen reductive splitting by multicopper oxidases Marta Ferraroni1, Nina M Myasoedova2, Vadim Schmatchenko2, Alexey A Leontievsky2, Ludmila A Golovleva2, Andrea Scozzafava1 and Fabrizio Briganti*1 Address: 1Department of Chemistry University of Florence, Via della Lastruccia 3, Sesto Fiorentino, 50019 Florence, Italy and 2G. K. Skryabin Institute of Biochemistry and Physiology of Microorganisms Russian Accademy of Science, Pushchino, Moscow Region, 1422920, Russia Email: Marta Ferraroni - [email protected]; Nina M Myasoedova - [email protected]; Vadim Schmatchenko - [email protected]; Alexey A Leontievsky - [email protected]; Ludmila A Golovleva - [email protected]; Andrea Scozzafava - [email protected]; Fabrizio Briganti* - [email protected] * Corresponding author Published: 26 September 2007 Received: 28 March 2007 Accepted: 26 September 2007 BMC Structural Biology 2007, 7:60 doi:10.1186/1472-6807-7-60 This article is available from: http://www.biomedcentral.com/1472-6807/7/60 © 2007 Ferraroni et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Laccases belong to multicopper oxidases, a widespread class of enzymes implicated in many oxidative functions in pathogenesis, immunogenesis and morphogenesis of organisms and in the metabolic turnover of complex organic substances. -
Electron Transfer and Substrate Reduction in Nitrogenase
Utah State University DigitalCommons@USU All Graduate Theses and Dissertations Graduate Studies 5-2014 Electron Transfer and Substrate Reduction in Nitrogenase Karamatullah Danyal Utah State University Follow this and additional works at: https://digitalcommons.usu.edu/etd Part of the Biochemistry Commons Recommended Citation Danyal, Karamatullah, "Electron Transfer and Substrate Reduction in Nitrogenase" (2014). All Graduate Theses and Dissertations. 2181. https://digitalcommons.usu.edu/etd/2181 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@USU. It has been accepted for inclusion in All Graduate Theses and Dissertations by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. ELECTRON TRANSFER AND SUBSTRATE REDUCTON IN NITROGENASE by Karamatullah Danyal A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biochemistry Approved: ________________________ _______________________ Lance C. Seefeldt Scott A. Ensign Major Professor Committee Member ________________________ _______________________ Alvan C. Hengge Sean J. Johnson Committee Member Committee Member ________________________ _______________________ Korry Hintze Mark R. McLellan Committee Member Vice President for Research and Dean of the School of Graduate Studies UTAH STATE UNIVERSITY Logan, Utah 2014 ii Copyright © Karamatullah Danyal 2014 All Rights Reserved iii ABSTRACT Electron Transfer and Substrate Reduction in Nitrogenase by Karamatullah Danyal, Doctor of Philosophy Utah State University, 2014 Major Professor: Dr. Lance C. Seefeldt Department: Chemistry and Biochemistry Population growth over the past ~50 years accompanied by the changes in dietary habits due to economic growth have markedly increased the demand for fixed nitrogen. Aided by biological nitrogen fixation, the Haber-Bosch process has been able to fulfill these demands.